Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Clear Cell Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
ABEMA Alone or in COMBO With MK-6482
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC
- Status
- COMPLETED
- Phase
- PHASE1
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC
- Status
- COMPLETED
- Phase
- N/A
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study
- Status
- COMPLETED
- Phase
- PHASE3
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib
- Status
- UNKNOWN
- Phase
- PHASE2
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1